Possible effect of histamine-2 receptor blockade on the antitumour response to interleukin-2

This publication has 5 references indexed in Scilit:

• Inpatient continuous-infusion interleukin-2 in 788 patients with cancer the national biotherapy study group experience
  Cancer, 1993
• Lowest dose interleukin-2 immunotherapy [see comments]
  Blood, 1993
• Treatment of metastatic renal cell carcinoma by continuous intravenous infusion of recombinant interleukin-2: a single-center phase II study.
  Journal of Clinical Oncology, 1992
• Modulation of Histamine Type II Receptors on CD8+ T Cells by lnterleukin-2 and Cimetidine
  International Archives of Allergy and Immunology, 1992
• Demonstration of histamine H2 receptors on human melanoma cells
  Biochemical and Biophysical Research Communications, 1988